Completed PHASE2 INTERVENTIONAL 4-arm NCT03487913

The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease

A Phase 2, Open-Label, Multi-Center Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease

Sponsor: Palladio Biosciences

Conditions Autosomal Dominant Polycystic Kidney Disease

Interventions Lixivaptan

Updated 22 times since 2018 Last updated: Nov 8, 2022 Started: Sep 14, 2018 Primary completion: Dec 2, 2019 Completion: Feb 11, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03487913, this PHASE2 trial focuses on Autosomal Dominant Polycystic Kidney Disease and remains completed. Sponsored by Palladio Biosciences, it has been updated 22 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

22 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Sep 2022 — Jan 2023 [monthly]

Completed PHASE2
Apr 2022 — Sep 2022 [monthly]

Completed PHASE2

▶ Show 17 earlier versions

Jan 2021 — Apr 2022 [monthly]

Completed PHASE2
Dec 2020 — Jan 2021 [monthly]

Completed PHASE2
Sep 2020 — Dec 2020 [monthly]

Completed PHASE2
Mar 2020 — Sep 2020 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Feb 2020 — Mar 2020 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Nov 2019 — Feb 2020 [monthly]

Recruiting PHASE2
Jun 2019 — Nov 2019 [monthly]

Recruiting PHASE2
Apr 2019 — Jun 2019 [monthly]

Recruiting PHASE2
Feb 2019 — Apr 2019 [monthly]

Recruiting PHASE2
Jan 2019 — Feb 2019 [monthly]

Recruiting PHASE2
Dec 2018 — Jan 2019 [monthly]

Recruiting PHASE2
Nov 2018 — Dec 2018 [monthly]

Recruiting PHASE2
Oct 2018 — Nov 2018 [monthly]

Recruiting PHASE2
Sep 2018 — Oct 2018 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Aug 2018 — Sep 2018 [monthly]

Not Yet Recruiting PHASE2
Jun 2018 — Aug 2018 [monthly]

Not Yet Recruiting PHASE2
May 2018 — Jun 2018 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Palladio Biosciences

Data source: Palladio Biosciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Baltimore, United States , Indiana, United States , Jacksonville, United States , Kansas City, United States , Laurelton, United States , Los Angeles, United States , Miami, United States , Nashville, United States , Palmetto Bay, United States , Rochester, United States and 2 more locations